ID	Database	Citation
map05223	KEGG Pathway	
12024041	Pubmed	"The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. Mol Cell Biol. 2002 Jun;22(12):4309–18.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/12024041"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/12024041"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/12024041"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
15948711	Pubmed	"Methylation of the tumor suppressor gene RASSF1A in human tumors. Pfeifer GP, Dammann R. Biochemistry (Mosc). 2005 May;70(5):576–83.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/15948711"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/15948711"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/15948711"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
17328863	Pubmed	"Induction of apoptosis by tumor suppressor FHIT via death receptor signaling pathway in human lung cancer cells. Deng WG, Nishizaki M, Fang B, Roth JA, Ji L. Biochem Biophys Res Commun. 2007 Apr 20;355(4):993–9.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/17328863"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/17328863"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/17328863"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
17625570	Pubmed	"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Nature. 2007 Aug 2;448(7153):561–6.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/17625570"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/17625570"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/17625570"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
17878233	Pubmed	"The RASSF1A tumor suppressor. Donninger H, Vos MD, Clark GJ. J Cell Sci. 2007 Sep 15;120(Pt 18):3163–72.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/17878233"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/17878233"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/17878233"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
20418096	Pubmed	"The biology and treatment of EML4-ALK non-small cell lung cancer. Sasaki T, Rodig SJ, Chirieac LR, Jänne PA. Eur J Cancer. 2010 Jul;46(10):1773–80.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/20418096"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/20418096"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/20418096"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
20979469	Pubmed	"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, Maki RG, et al. N Engl J Med. 2010 Oct 28;363(18):1693–703.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/20979469"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/20979469"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/20979469"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
23322901	Pubmed	"Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Connolly RM, Nguyen NK, Sukumar S. Clin Cancer Res. 2013 Apr 1;19(7):1651–9.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/23322901"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/23322901"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/23322901"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
25514926	Pubmed	"PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Hornbeck PV, Zhang B, Murray B, Kornhauser JM, Latham V, Skrzypek E. Nucleic Acids Res. 2015 Jan;43(Database issue):D512-20.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/25514926"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/25514926"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/25514926"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
28572459	Pubmed	"AACR Project GENIE: Powering Precision Medicine through an International Consortium. AACR Project GENIE Consortium. Cancer Discov. 2017 Aug;7(8):818–31.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/28572459"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/28572459"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/28572459"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
28675058	Pubmed	"Selumetinib for the treatment of non-small cell lung cancer. Casaluce F, Sgambato A, Maione P, Sacco PC, Santabarbara G, Gridelli C. Expert Opin Investig Drugs. 2017 Aug;26(8):973–84.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/28675058"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/28675058"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/28675058"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
29128428	Pubmed	"Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung Cancer. Ferrara R, Auger N, Auclin E, Besse B. J Thorac Oncol. 2018 Jan;13(1):27–45.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/29128428"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/29128428"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/29128428"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
29438093	Pubmed	"FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations. Odogwu L, Mathieu L, Blumenthal G, Larkins E, Goldberg KB, Griffin N, et al. Oncologist. 2018 Jun;23(6):740–5.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/29438093"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/29438093"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/29438093"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
34118197	Pubmed	"Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study. Gainor JF, Curigliano G, Kim DW, Lee DH, Besse B, Baik CS, et al. Lancet Oncol. 2021 Jul;22(7):959–69.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/34118197"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/34118197"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/34118197"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
38357801	Pubmed	"A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer. Riely GJ, Smit EF, Ahn MJ, Felip E, Ramalingam SS, Tsao A, et al. Future Oncol. 2024;20(16):1047–55.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/38357801"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/38357801"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/38357801"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
39983053	Pubmed	"Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial. Gautschi O, Park K, Solomon BJ, Tomasini P, Loong HH, De Braud F, et al. J Clin Oncol. 2025 May 20;43(15):1758–64.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/39983053"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/39983053"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://qlever.scholia.wiki/pubmed/39983053"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
